Safety and efficacy of lenalidomide and prednisone therapy in Japanese elderly patients with multiple myeloma, a phase II study
Phase 2
Recruiting
- Conditions
- Multiple Myeloma
- Registration Number
- JPRN-UMIN000007945
- Lead Sponsor
- ara Hospital Kinki University School Of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
.Cardiac infarction within 6 months .Deep vein thrombosis or pulmonary embolism within 3 years .Tuberculosis, herpes simplex keratitis, mycosis, or other active infections at baseline .Uncontrollable diabetes mellitus, hypertension, peptic ulcer, or glaucoma .Posterior capsule opacification .Patients with mental illness .Those who are considered as inappropriate to register by attending physicians .Pregnant or breast feeding females .Known hypersensitivity to prednisone
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Best response rate
- Secondary Outcome Measures
Name Time Method Rate of adverse events Duration of response Progression-free survival Overall survival